216 related articles for article (PubMed ID: 9413810)
21. Mazabraud syndrome associated with McCune-Albright syndrome: a case report and review of the literature.
Biazzo A; Di Bernardo A; Parafioriti A; Confalonieri N
Acta Biomed; 2017 Aug; 88(2):198-200. PubMed ID: 28845837
[TBL] [Abstract][Full Text] [Related]
22. Etiology of fibrous dysplasia and McCune-Albright syndrome.
Cohen MM; Howell RE
Int J Oral Maxillofac Surg; 1999 Oct; 28(5):366-71. PubMed ID: 10535539
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone-secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndrome.
Ihara C; Shimatsu A; Murabe H; Kataoka K; Kondo C; Nakao K
J Endocrinol Invest; 1996 Dec; 19(11):753-7. PubMed ID: 9061509
[TBL] [Abstract][Full Text] [Related]
24. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
Jung AJ; Soskin S; Paris F; Lipsker D
Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.
Ringel MD; Schwindinger WF; Levine MA
Medicine (Baltimore); 1996 Jul; 75(4):171-84. PubMed ID: 8699958
[TBL] [Abstract][Full Text] [Related]
26. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
Marie PJ; de Pollak C; Chanson P; Lomri A
Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
[TBL] [Abstract][Full Text] [Related]
27. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome.
Weinstein LS
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000
[TBL] [Abstract][Full Text] [Related]
28. A novel, complex heterozygous mutation within Gsalpha gene in patient with McCune-Albright syndrome.
Song HD; Chen FL; Shi WJ; Wang S; Zhang Q; Hu RM; Chen JL
Endocrine; 2002 Jul; 18(2):121-8. PubMed ID: 12374458
[TBL] [Abstract][Full Text] [Related]
29. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome.
Karadag A; Riminucci M; Bianco P; Cherman N; Kuznetsov SA; Nguyen N; Collins MT; Robey PG; Fisher LW
Nucleic Acids Res; 2004 Apr; 32(7):e63. PubMed ID: 15096559
[TBL] [Abstract][Full Text] [Related]
30. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
Alman BA; Greel DA; Wolfe HJ
J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
[TBL] [Abstract][Full Text] [Related]
31. McCune-Albright syndrome: molecular genetics.
Lumbroso S; Paris F; Sultan C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():875-82. PubMed ID: 12199345
[TBL] [Abstract][Full Text] [Related]
32. Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome.
Romanet P; Philibert P; Fina F; Cuny T; Roche C; Ouafik L; Paris F; Reynaud R; Barlier A
J Pediatr; 2019 Feb; 205():281-285.e4. PubMed ID: 30442414
[TBL] [Abstract][Full Text] [Related]
33. [A case of fibrous dysplasia (McCune Albright syndrome) associated with acromegaly].
Chiba Y; Tani N; Tamura N; Nakamura H; Igarashi K; Momotsu T; Tsuda A; Ito S; Shibata A; Tamura T
Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67(3):239-48. PubMed ID: 2070893
[TBL] [Abstract][Full Text] [Related]
34. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia.
Boston BA; Mandel S; LaFranchi S; Bliziotes M
J Clin Endocrinol Metab; 1994 Sep; 79(3):890-3. PubMed ID: 8077378
[TBL] [Abstract][Full Text] [Related]
35. Polyostotic fibrous dysplasia (McCune-Albright) with rare multiple epiphyseal lesions in association with aneurysmal bone cyst and pathologic fracture.
Burdiles A; Marín R; Klaber I; Solar A; Calderón M; Jara F; Kara F; Bazáes D
Radiol Case Rep; 2021 Sep; 16(9):2719-2725. PubMed ID: 34336077
[TBL] [Abstract][Full Text] [Related]
36. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.
Lumbroso S; Paris F; Sultan C;
J Clin Endocrinol Metab; 2004 May; 89(5):2107-13. PubMed ID: 15126527
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
[TBL] [Abstract][Full Text] [Related]
38. McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.
Vasilev V; Daly AF; Thiry A; Petrossians P; Fina F; Rostomyan L; Silvy M; Enjalbert A; Barlier A; Beckers A
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2029-38. PubMed ID: 25062453
[TBL] [Abstract][Full Text] [Related]
39. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
[TBL] [Abstract][Full Text] [Related]
40. Fibrous dysplasia protuberans in a patient with McCune-Albright syndrome.
Hamadani M; Awab A; Rashid A; Ali T; Brown B
J Coll Physicians Surg Pak; 2006 May; 16(5):376-7. PubMed ID: 16756788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
